Authorization

Eisai to Present New Investigational Data on LENVIMA® (lenvatinib) in Thyroid Cancer and Osteosarcoma at ESMO Asia 2020

WOODCLIFF LAKE, N.J., Nov. 19, 2020 /PRNewswire/ --A Eisai announced today the presentation of three abstracts including investigational data in thyroid cancer and osteosarcoma at the European Society for Medical Oncology (ESMO) Asia Virtual Congress 2020 from November 20-22, 2020.
Eisai to Present New Investigational Data on LENVIMA® (lenvatinib) in Thyroid Cancer and Osteosarcoma at ESMO Asia 2020
New safety and efficacy data on LENVIMA (lenvatinib), an orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, will be presented from two trials in patients with radioactive iodine-refractory differentiated thyroid cancer (RAI-refractory DTC). Presentations include results from Study 211, a Phase 2 study evaluating and comparing the starting dose of LENVIMA (18 mg vs 24 mg) (Abstract #426P), as well as results from Study 308, a pivotal Phase 3 trial showing that LENVIMA significantly prolonged progression free survival (PFS) compared to placebo in patients in China (Abstract #421P).A Eisai will also be presenting a Trials in Progress e-poster of Study 230 (NCT04154189), a Phase 2 trial, evaluating ifosfamide and etoposide with and without LENVIMA in children, adolescents and young adults with relapsed or refractory osteosarcoma. (Abstract #443TiP). "At this year's ESMO Asia, Eisai continues to build on its research for patients by delivering new investigational data on LENVIMA in RAI-refractory DTC and osteosarcoma, the most common type of bone cancer," saidA Dr.A Takashi Owa, Vice President, Chief Medicine Creation Officer and Chief Discovery Officer, Oncology Business Group at Eisai. "We believe the deepening of the global body of evidence on these therapies will enhance our understanding of their clinical value, thus furthering our full dedication to serving patients and their families a?? our core corporate mission illustrated by our human health care philosophy."
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2021    »
ПнВтСрЧтПтСбВс
 123
45678910
11121314151617
18192021222324
25262728293031